The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

In patients with protein C and protein S deficiency, when warfarin therapy is started there is a more rapid fall in concentration of protein C (antigen and activity) than the other vitamin K ...

The FDA has approved Emrelis to treat adults with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung ...

Oatmeal is rich in fiber, the plant-based carbohydrate that boosts digestion and lowers cholesterol levels. Foods with more ...

FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes ...

Liverpool nutrition and functional foods brand Protein Works has expanded its C-suite as part of its plans to reach revenue of £100m in the next five years. The business ...

The FDA granted accelerated approval to telisotuzumab vedotin (Emrelis) for the treatment of adults with previously treated, ...

Following the approval, ABBV's Emrelis becomes the first FDA-approved therapy for previously treated advanced NSCLC patients ...

Discover lesser-known Indian vegan proteins like Amaranth Rajgira and Chana Sattu. Boost your diet sustainably with ...

Eating more minimally processed plant-based proteins – such as beans, nuts and lentils – may lower the risk for high blood ...

AbbVie's Emrelis is the first non-small cell lung cancer therapy approved for patients with high c-Met expression levels who ...